Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Open-label Phase	STARTED	Pantoprazole Sodium Granules	129
Open-label Phase	STARTED	Placebo	0
Open-label Phase	COMPLETED	Pantoprazole Sodium Granules	107
Open-label Phase	COMPLETED	Placebo	0
Open-label Phase	NOT COMPLETED	Pantoprazole Sodium Granules	22
Open-label Phase	NOT COMPLETED	Placebo	0
Double-blind Phase	STARTED	Pantoprazole Sodium Granules	54
Double-blind Phase	STARTED	Placebo	54
Double-blind Phase	COMPLETED	Pantoprazole Sodium Granules	43
Double-blind Phase	COMPLETED	Placebo	45
Double-blind Phase	NOT COMPLETED	Pantoprazole Sodium Granules	11
Double-blind Phase	NOT COMPLETED	Placebo	9

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00365300/flow